Lewes, Delaware (PRWEB) November 27, 2013
The growing prevalence of pressure ulcers will boost the pressure relief devices market, which is expected to increase from $2.9 billion in 2012 to $4.1 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 4.7%, reveals new report on medical devices industry.
According to the latest report, the increase in pressure ulcers will drive the demand for pressure-relieving devices, such as therapeutic support surfaces, mattresses and overlays. Previous research shows that more than 2.5 million Americans are expected to develop this condition every year.
The rising prevalence of obesity will also drive the pressure relief devices market growth. Obese patients are at increased risk of developing pressure ulcers, as they are required to stay in hospital for longer periods, and have slower wound-healing times.
According to the author of this report : “As pressure ulcers cause pain and increase the risk of skin infection, caregivers should focus on protecting patients from high-risk pressure sores using appropriate prevention strategies. These include pressure-relieving support surfaces, such as bariatric beds with multiple functionalities.”
However, the high costs and lack of reimbursement surrounding treatment for pressure ulcers could prove major restraints for future market growth.
Author continues: “Treatment is expensive due to long hospitalization periods, slow healing times, recurring wounds and an increased chance of infection. On top of this, the US Medicare does not provide reimbursement for the treatment of hospital-acquired pressure ulcers.”
Leading global manufacturers are therefore focusing on emerging markets, such as India and China, in order to expand their customer base and sales.
This report looks at the market, competitive landscape, and trends for the four pressure relief devices market segments: mattress overlays, specialty beds (rentals), specialty beds (sales), and mattresses. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis.
For more information on global pressure relief devices market report please visit: http://www.marketresearchreports.com/gbi-research/pressure-relief-devices-market-2019-increasing-focus-pressure-ulcer-prevention-and
Other related reports:
Prostate Cancer Therapeutics Market to 2019: Due to the growing prevalence of prostate cancer and the launch of new products for the condition, the prostate cancer treatment market will increase from $4.1 billion in 2012 to $8 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 10.1%.
New report reveals that the overall prevalence of prostate cancer across the eight leading markets (the US, UK, France, Germany, Italy, Spain, Japan and Canada) is expected to increase from 3.3 million in 2012 to 3.9 million by 2019. For more information on this report please: http://www.marketresearchreports.com/gbi-research/prostate-cancer-therapeutics-market-2019-rising-prevalence-and-strong-uptake-recent
Ophthalmology Therapeutics Market in Asia-Pacific to 2019: The ophthalmology therapeutics market for Dry Eye Syndrome (DES) and glaucoma in four Asia-Pacific (APAC) countries — India, Australia, China and Japan — will increase from $2.4 billion in 2012 to $3.3 billion in 2019, at a Compound Annual Growth Rate (CAGR) of 5%.
In 2012, Japan had the largest share of the ophthalmology market with a share of $1,065m (45%), followed by China, India and Australia with shares of $767m (33%), $427m (18%) and $95m (4%), respectively. For more information on this report, please visit: http://www.marketresearchreports.com/gbi-research/ophthalmology-therapeutics-market-asia-pacific-2019-high-unmet-need-and-moderate-short
Alzheimer's Disease Therapeutics Market to 2019: As a result of Phase III therapy LMTX potentially entering the Alzheimer’s Disease (AD) industry in the near future, the AD market will increase slightly from $3.6 billion in 2012 to $3.8 billion in 2019, the current AD market with the available products is in serious decline.
However, this could be offset by LMTX should it be approved, which is far from certain in a market characterized by one of the highest attrition rates across the industry. Such decline is due to the limited late-stage pipeline as well as the patent expiration of all current treatments. For more information on this report please: http://www.marketresearchreports.com/gbi-research/alzheimers-disease-therapeutics-market-2019-early-stage-innovation-points-disease
To browse more pharmaceuticals and healthcare reports, please visit http://www.marketresearchreports.com/pharma-healthcare.
To browse more medical devices reports, please visit: http://www.marketresearchreports.com/medical-devices.
About Market Research Reports, Inc
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
Mr. Amitava Sen
General Manager - Sales & Marketing
Market Research Reports, Inc.
Tel USA: +1-302-703-7787
Tel India: +91-80-26860858
Subscribe us on YouTube: http://www.youtube.com/user/MarketResearchReport